Alzheimer's disease: Genetic risks and amyloid-beta protein links to brain atrophy

Recent research and medical insights are clarifying the relationship between genetics and Alzheimer's disease. While many fear the condition is directly hereditary, medical experts note that strictly hereditary Alzheimer's is rare, accounting for only 1% to 5% of cases. Most instances are linked to aging and environmental factors. Genetic mutations in the APP, PSEN1, or PSEN2 genes are typically associated with early-onset cases occurring before age 65, whereas late-onset cases are often influenced by the APOE ε4 gene variant, which acts as a risk indicator rather than a certainty.

Complementary findings from the AMYPAD Prognostic and Natural History Study indicate that amyloid-beta accumulation in the brain can predict future brain atrophy in older individuals who still maintain cognitive function. This association was particularly strong in women regarding temporal region atrophy. The presence of at least one APOE-ε4 allele further strengthens the link between amyloid-beta buildup and atrophy in the frontal, lateral-temporal, and hippocampal regions. These pathological changes, including the buildup of amyloid-beta plaques and tau proteins, often begin years before clinical dementia symptoms manifest.